ストックスクリーナーアプリを入手
12.33
1.99%
0.24
アフターアワーズ：
12.39
0.06
+0.49%
Xencor Inc (XNCR) 最新ニュース
Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution - Yahoo Finance
Xencor Inc Stock (US98401F1057): Analyst Views In Focus After Recent Collaboration Momentum - AD HOC NEWS
Understanding Momentum Shifts in (XNCR) - Stock Traders Daily
Xencor (XNCR) Slides 2% as Biotech Sentiment Weakens — Support TestedTRIN Signal - newsline.com
Incyte lymphoma therapy lifts cancer-free survival by 25% in late-stage trial - MSN
Xencor Inc stock (US98401F1057): shares react to Monjuvi first-line lymphoma update and recent Q1 20 - AD HOC NEWS
XNCR Technical Analysis & Stock Price Forecast - Intellectia AI
XNCR Q1 2026 Earnings: Deep Loss Miss as Pipeline Biotech Faces Market SkepticismInterim Report - The Legal Advocate
XNCR Q1 2026 Earnings: Significant EPS Miss Amidst Clinical Development ProgressAnnual Report - newsline.com
XNCR Q1 2026 Earnings: Deeper-than-Expected Loss Highlights Persistent R&D InvestmentEarnings Revision Upgrade - newsline.com
Xencor Inc stock (US98401F1057): shares trade around recent lows as investors digest pipeline and va - AD HOC NEWS
Avoiding Lag: Real-Time Signals in (XNCR) Movement - Stock Traders Daily
XNCR Q1 2026 Earnings: Large EPS Miss Amid Pre-Revenue Status; Stock Gains SlightlyEarnings Acceleration Picks - newsline.com
Xencor Inc. (XNCR) Holds Ground Near $11.31: Key Levels in FocusComposite Profile - Newser
Jefferies Financial Group Inc. Purchases 620,440 Shares of Xencor, Inc. $XNCR - MarketBeat
Xencor, Inc. (XNCR) Competitors - Meyka
Xencor Inc. (XNCR) Holds Near Support as Biotech Sector Shows Mixed SignalsCrowd Entry Points - Newser
Xencor (XNCR) Q1 2026 Underperforms: Key Challenges AheadPro Level Trade Signals - Newser
Xencor’s SWOT analysis: biotech stock faces pipeline execution test - Investing.com
Xencor’s SWOT analysis: biotech stock faces pipeline execution test By Investing.com - Investing.com Canada
Xencor (XNCR) Q1 2026 Disappoints — EPS $-1.71 Below $-0.79 ViewsPopular Trader Picks - Newser
T-cell Engagers Market to Record US$ 58.04 billion by 2035., - openPR.com
Xencor Inc stock (US98401F1057): JPMorgan lifts target while investors eye Q1 2026 update - AD HOC NEWS
Xencor, Inc. $XNCR Shares Sold by UBS Group AG - MarketBeat
EcoR1 reports 2.9% Xencor stake (NASDAQ: XNCR) - Stock Titan
Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR) - The Globe and Mail
Xencor stock (US98401F1057): Biotech focus on immunotherapy and protein engineering - AD HOC NEWS
Xencor (XNCR) Declines -2.50% Amid Market Weakness 2026-05-14Undervalued Stocks - Newser
TradingKey - TradingKey
Xencor stock (US98401F1057): Biotech innovator in antibody therapies - AD HOC NEWS
Xencor Is Maintained at Neutral by JP Morgan - Moomoo
TD Cowen Maintains Xencor(XNCR.US) With Buy Rating - Moomoo
J.P. Morgan Maintains Xencor(XNCR.US) With Hold Rating, Raises Target Price to $14 - Moomoo
Xencor (NASDAQ:XNCR) Price Target Raised to $14.00 at JPMorgan Chase & Co. - MarketBeat
These Analysts Just Made A Huge Downgrade To Their Xencor, Inc. (NASDAQ:XNCR) EPS Forecasts - simplywall.st
XNCR (Xencor) crushes Q4 estimates with 85% earnings surprise, revenue rises 13.7%, shares jump 4.5%.Open Signal Network - Newser
Xencor (NASDAQ:XNCR) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Xencor (XNCR) Receives a Buy from Wells Fargo - The Globe and Mail
These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat - Yahoo Finance
Xencor (NASDAQ:XNCR) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
Xencor, Inc. (XNCR) Stock Analysis: Exploring A 132% Potential Upside In Biotech - DirectorsTalk Interviews
What Xencor (XNCR) is doing to earn customer loyalty (Falls Hard) 2026-05-08Double EMA - newsline.com
MSN Money - MSN
Number of shareholders of Xencor, Inc. – MUN:XE9 - TradingView
Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Xencor (NASDAQ:XNCR) Releases Earnings Results, Misses Estimates By $1.06 EPS - MarketBeat
Earnings Flash (XNCR) Xencor, Inc. Reports Q1 Revenue $4.5M - marketscreener.com
Xencor: Q1 Earnings Snapshot - marketscreener.com
Xencor (NASDAQ: XNCR) posts deeper Q1 2026 loss amid royalty dispute and Zenas write-down - Stock Titan
Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Xencor (NASDAQ: XNCR) Q1 loss widens as revenue and royalties fall - Stock Titan
Xencor Reports First Quarter 2026 Financial Results - Business Wire
Xencor trying to close in on key technical benchmark - MSN
Xencor Highlights XmAb942 Phase 1 Data, Previews TL1A/IL-23 Bispecific XmAb412 at DDW 2026 - MarketBeat
Buy Rating on Xencor as TL1A Franchise Data and Upcoming Phase IIb Catalyst Support Upside Potential - TipRanks
1.04%
0.76%
大文字化:
|
ボリューム (24 時間):